Influenza (epidemics/pandemics)

Host Defence Peptides


Completed trials

Posters and publications



Wide, rapid action combined with unlikely resistance development

The compound LTX-109 has a proven effect against a variety of bacteria, both gram positives and gram negatives, including multi-resistant bacteria such as MRSA, and difficult-to-treat bacteria such as Pseudomonas aeruginosa in addition to biofilm. It exerts its bactericidal effect through disrupting the integrity of bacterial cell membrane, inducing lysis of the bacteria. The effect is also proven in vitro against certain types of fungi and viruses. The rapid mechanism of action not only enables treating infections faster, but also reduces the likelihood of resistance to our drug.